About the Company
We do not have any company description for Petros Pharmaceuticals, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PTPI News
Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health
Collaboration with leading telemedicine provider to offer marketing and distribution of STENDRA for Lemonaid Health's ED ...
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
Petros Pharmaceuticals CEO Fady Boctor joined Steve Darling from Proactive to share exciting developments with Proactive, ...
PTPI Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men’s health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications ...
Petros Pharmaceuticals Inc Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Petros Pharma Stock Down, Despite Positive Results For Stendra Study
(RTTNews) - Petros Pharmaceuticals, Inc. (PTPI) shares are declining more than 21 percent on Tuesday morning trade, continuing a bearish trend since last week. Petros Pharma reported positive ...
Positive Outlook for Petros Pharmaceuticals: Buy Rating Affirmed Amidst FDA Advances and Promising Stendra Developments
In a report released yesterday, Naz Rahman from Maxim Group maintained a Buy rating on Petros Pharmaceuticals (PTPI – Research Report), ...
Petros Pharmaceuticals partners with Lemonaid Health for ED drug distribution
NEW YORK - Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a firm dedicated to improving consumer access to over-the-counter (OTC) medications, has announced a collaboration with Lemonaid Health ...
Petros Pharmaceuticals Inc (PTPI)
At the close... Petros Pharmaceuticals, Inc. (PTPI) announces a new partnership with a leading, multi-billion-dollar AI software provider to adapt its technology for self-screening and other ...
Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA Through New Agreement with Lemonaid Health
Collaboration with leading telemedicine provider to offer marketing and distribution of STENDRA for Lemonaid Health's ED patients(Please see important safety information below)NEW YORK, NY / ACCESSWIR ...
Petros Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Petros Pharmaceuticals Inc Ordinary Shares PTPI
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Loading the latest forecasts...